Osama Abdelghany, PharmD, explains how medically integrated dispensing improves oncology workflows, patient access, and outcomes through EMR-driven care.
Sam Abdelghany, PharmD, MHA
Advertisement
Sam Abdelghany, PharmD, is an executive director of oncology pharmacy at Smilow Cancer Hospital at Yale-New Haven Health.
Articles by Sam Abdelghany, PharmD, MHA
Medically integrated dispensing improves oncology treatment coordination through EMR-based care, but payer restrictions remain a key barrier.
The foundation of medically integrated pharmacy includes 7 critical pillars. This commentary focuses on the benefits of 3 of those pillars: abandonment, adherence, and access/affordability.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs
2
Oral COVID-19 PEP May Benefit High-Risk Groups More Than General Public: Peter J. Hotez, MD
3
Walcker Named President of Cardinal’s The Specialty Alliance, With Strengths in GI, Urology
4
Fourteen Years of HIV PrEP: How New Innovations Build on Decades of Progress in HIV
5